Mathew Blackman
Stock Analyst at Stifel
(3.40)
# 949
Out of 5,072 analysts
61
Total ratings
58.14%
Success rate
15.08%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mathew Blackman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INGN Inogen | Maintains: Hold | $10 → $7 | $7.17 | -2.37% | 13 | May 8, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $60 → $31 | $21.03 | +47.44% | 6 | May 1, 2025 | |
| PEN Penumbra | Maintains: Buy | $301 → $318 | $293.17 | +8.47% | 2 | Apr 24, 2025 | |
| CLPT ClearPoint Neuro | Maintains: Buy | $19 → $25 | $14.46 | +72.89% | 3 | Apr 1, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $25 | $31.34 | -20.23% | 1 | Feb 24, 2025 | |
| PODD Insulet | Maintains: Hold | $245 → $293 | $327.19 | -10.45% | 5 | Feb 21, 2025 | |
| GMED Globus Medical | Maintains: Buy | $92 → $94 | $91.04 | +3.25% | 5 | Feb 21, 2025 | |
| OFIX Orthofix Medical | Upgrades: Buy | $18 → $24 | $16.06 | +49.49% | 5 | Nov 8, 2024 | |
| CERS Cerus | Maintains: Buy | $6 → $3 | $1.76 | +70.45% | 1 | Oct 17, 2024 | |
| DXCM DexCom | Maintains: Buy | $90 → $100 | $63.47 | +57.55% | 11 | Aug 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $16 | $22.55 | -29.05% | 5 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $18 → $11 | $9.65 | +13.99% | 4 | May 10, 2023 |
Inogen
May 8, 2025
Maintains: Hold
Price Target: $10 → $7
Current: $7.17
Upside: -2.37%
Tandem Diabetes Care
May 1, 2025
Maintains: Buy
Price Target: $60 → $31
Current: $21.03
Upside: +47.44%
Penumbra
Apr 24, 2025
Maintains: Buy
Price Target: $301 → $318
Current: $293.17
Upside: +8.47%
ClearPoint Neuro
Apr 1, 2025
Maintains: Buy
Price Target: $19 → $25
Current: $14.46
Upside: +72.89%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $25
Current: $31.34
Upside: -20.23%
Insulet
Feb 21, 2025
Maintains: Hold
Price Target: $245 → $293
Current: $327.19
Upside: -10.45%
Globus Medical
Feb 21, 2025
Maintains: Buy
Price Target: $92 → $94
Current: $91.04
Upside: +3.25%
Orthofix Medical
Nov 8, 2024
Upgrades: Buy
Price Target: $18 → $24
Current: $16.06
Upside: +49.49%
Cerus
Oct 17, 2024
Maintains: Buy
Price Target: $6 → $3
Current: $1.76
Upside: +70.45%
DexCom
Aug 23, 2024
Maintains: Buy
Price Target: $90 → $100
Current: $63.47
Upside: +57.55%
Aug 1, 2024
Maintains: Buy
Price Target: $19 → $16
Current: $22.55
Upside: -29.05%
May 10, 2023
Downgrades: Hold
Price Target: $18 → $11
Current: $9.65
Upside: +13.99%